Surgery for gastroesophageal reflux disease: esophageal impedance to progress?
- PMID: 19683073
- PMCID: PMC2789853
- DOI: 10.1016/j.cgh.2009.08.003
Surgery for gastroesophageal reflux disease: esophageal impedance to progress?
Comment on
-
Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis.Clin Gastroenterol Hepatol. 2009 Dec;7(12):1292-8; quiz 1260. doi: 10.1016/j.cgh.2009.05.021. Epub 2009 May 31. Clin Gastroenterol Hepatol. 2009. PMID: 19490952
References
-
- Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology. 1997;112:1798–810. - PubMed
-
- Castell DO, Kahrilas PJ, Richter JE, Vakil NB, Johnson DA, Zuckerman S, Skammer W, Levine JG. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol. 2002;97:575–83. - PubMed
-
- Nealis TB, Howden CW. Is there a dark side to long-term proton pump inhibitor therapy? Am J Ther. 2008;15:536–42. - PubMed
-
- Theisen J, Nehra D, Citron D, Johansson J, Hagen JA, Crookes PF, DeMeester SR, Bremner CG, DeMeester TR, Peters JH. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg. 2000;4:50–4. - PubMed
-
- Lundell . report in this issue of CGH.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
